GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 84 filers reported holding GENERATION BIO CO in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $604,642 | -33.9% | 159,536 | -4.1% | 0.00% | – |
| Q2 2023 | $915,206 | +31.9% | 166,401 | +3.1% | 0.00% | – |
| Q1 2023 | $693,861 | +7.7% | 161,363 | -1.6% | 0.00% | – |
| Q4 2022 | $644,241 | -26.6% | 163,929 | -0.9% | 0.00% | – |
| Q3 2022 | $878,000 | -8.3% | 165,415 | +13.3% | 0.00% | – |
| Q2 2022 | $957,000 | -9.0% | 145,941 | +1.8% | 0.00% | – |
| Q1 2022 | $1,052,000 | -75.6% | 143,405 | -76.4% | 0.00% | -100.0% |
| Q4 2021 | $4,307,000 | -73.2% | 608,299 | -5.2% | 0.00% | -66.7% |
| Q3 2021 | $16,092,000 | -3.8% | 641,857 | +3.2% | 0.00% | 0.0% |
| Q2 2021 | $16,735,000 | +3.6% | 622,073 | +9.6% | 0.00% | 0.0% |
| Q1 2021 | $16,154,000 | +93.7% | 567,594 | +93.0% | 0.00% | +50.0% |
| Q4 2020 | $8,339,000 | -7.4% | 294,162 | +1.0% | 0.00% | 0.0% |
| Q3 2020 | $9,005,000 | +1318.1% | 291,329 | +863.1% | 0.00% | – |
| Q2 2020 | $635,000 | – | 30,248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |